ORIC Pharmaceuticals, Inc.
ORIC
$13.87
$0.151.09%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 264.76M | 281.93M | 281.49M | 287.14M | 282.51M |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 8.93M | 8.30M | 6.98M | 8.45M | 8.61M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 273.70M | 290.23M | 288.47M | 295.59M | 291.12M |
|
|
|||||
| Total Current Assets | 273.70M | 290.23M | 288.47M | 295.59M | 291.12M |
| Net Property, Plant & Equipment | 2.24M | 2.15M | 9.07M | 2.56M | 2.76M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 5.95M | 6.60M | 589.00K | 7.13M | 7.76M |
| Total Assets | 404.69M | 436.76M | 408.89M | 431.19M | 346.86M |
|
|
|||||
| Total Accounts Payable | 3.87M | 2.90M | 3.82M | 2.90M | 3.13M |
| Total Accrued Expenses | 13.56M | 11.58M | 13.26M | 13.98M | 11.65M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 3.33M | 3.30M | 3.33M | 3.30M | 3.27M |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 20.76M | 17.77M | 20.42M | 20.18M | 18.05M |
|
|
|||||
| Total Current Liabilities | 20.76M | 17.77M | 20.42M | 20.18M | 18.05M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 2.67M | 3.43M | 4.11M | 4.09M | 4.81M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 23.43M | 21.21M | 24.53M | 24.27M | 22.86M |
|
|
|||||
| Common Stock & APIC | 1.15B | 1.14B | 1.08B | 1.07B | 952.96M |
| Retained Earnings | -769.50M | -728.01M | -692.24M | -661.74M | -629.15M |
| Treasury Stock & Other | -1.02M | -290.00K | 786.00K | 615.00K | 187.00K |
| Total Common Equity | 381.26M | 415.56M | 384.36M | 406.92M | 324.00M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 381.26M | 415.56M | 384.36M | 406.92M | 324.00M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 381.26M | 415.56M | 384.36M | 406.92M | 324.00M |
|
|
|||||